Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $18,568 - $21,052
387 Added 1.68%
23,480 $1.27 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $17,309 - $19,354
-299 Reduced 1.28%
23,093 $1.34 Million
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $19,113 - $21,222
300 Added 1.3%
23,392 $1.5 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $97 - $57,630
-750 Reduced 3.15%
23,092 $1.64 Million
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $8,098 - $9,440
151 Added 0.64%
23,842 $1.49 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $35,442 - $41,516
-599 Reduced 2.47%
23,691 $1.4 Million
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $137,130 - $149,335
-2,215 Reduced 8.36%
24,290 $1.62 Million
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $5,934 - $6,673
-100 Reduced 0.38%
26,505 $1.67 Million
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $46,192 - $52,344
-800 Reduced 2.92%
26,605 $1.65 Million
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $32,892 - $38,454
600 Added 2.24%
27,405 $1.61 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $21,344 - $31,017
460 Added 1.75%
26,805 $1.49 Million
Q4 2019

Jan 24, 2020

BUY
$49.21 - $64.19 $410,411 - $535,344
8,340 Added 46.32%
26,345 $1.69 Million
Q2 2019

Aug 02, 2019

BUY
$44.62 - $49.34 $17,848 - $19,736
400 Added 2.27%
18,005 $817,000
Q4 2018

Feb 04, 2019

BUY
$48.76 - $63.23 $20,479 - $26,556
420 Added 2.44%
17,605 $915,000
Q3 2018

Oct 22, 2018

SELL
$55.19 - $62.25 $2,759 - $3,112
-50 Reduced 0.29%
17,185 $1.07 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $17,180 - $21,413
-340 Reduced 1.93%
17,235 $954,000
Q1 2018

May 01, 2018

SELL
$59.92 - $68.98 $25,166 - $28,971
-420 Reduced 2.33%
17,575 $1.11 Million
Q4 2017

Jan 24, 2018

SELL
$59.94 - $65.35 $26,373 - $28,753
-440 Reduced 2.39%
17,995 $1.1 Million
Q3 2017

Oct 25, 2017

BUY
$55.23 - $63.74 $1.02 Million - $1.18 Million
18,435
18,435 $1.18 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Duff & Phelps Investment Management CO Portfolio

Follow Duff & Phelps Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Duff & Phelps Investment Management CO with notifications on news.